All Resources
Read all of the latest breakthroughs, insights, and news from Ginkgo.
BlogSeptember 24, 2024
Botswana’s Ministry of Health and Ginkgo Launch Pathogen Monitoring Program at Sir Seretse Khama International AirportBlogAugust 21, 2024
Ginkgo Teams up with Yale New Haven Hospital on Infection Control and Prevention through Wastewater TestingBlogApril 10, 2024
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles OutbreaksBlogApril 4, 2024
Concentric by Ginkgo becomes Ginkgo BiosecurityBlogMarch 18, 2024
Welcome Dr. Mitch Wolfe!BlogFebruary 27, 2024
Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free ZonesBlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes PublicBlogJune 9, 2021
600,000 Noses Swabbed!BlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNABlogMarch 18, 2021
Why Ginkgo Cares about Genetic PrivacyBlogDecember 8, 2020
Expanding Ginkgo's Platform for Biosecurity and Pandemic ResponsivenessBlogNovember 16, 2020
Webinar: University Leaders on TestingBlogOctober 23, 2020
Our New Seaport Test Center: Expanding Access to COVID-19 Diagnostic Testing in BostonBlogJune 30, 2020
Needle in a Haystack: Looking for Compounds to Treat COVID-19BlogJune 18, 2020
Concentric by Ginkgo: COVID-19 testing at scaleBlogMay 4, 2020
How to Deploy Millions of COVID-19 Tests Per DayBlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with ModernaBlogApril 10, 2020
Project Update: COVID-19 DNA SynthesisBlogMarch 24, 2020
Scaling Up Whole Genome Sequencing of COVID-19BlogMarch 22, 2020
Synthetic Biology (and beyond) Community response to COVID-19BlogMarch 20, 2020
Fighting COVID-19 by Synthesizing DNABlogMarch 17, 2020
$25M of Free Platform Access for COVID-19 ProjectsBlogJune 26, 2018
Our Work on Biosecurity with IARPA